Black Rock Inc. Collegium Pharmaceutical, Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Black Rock Inc. holds 5,793,383 shares of COLL stock, worth $171 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,793,383
Previous 5,865,899
1.24%
Holding current value
$171 Million
Previous $228 Million
18.08%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding COLL
# of Institutions
254Shares Held
37.2MCall Options Held
61.1KPut Options Held
5.8K-
Rubric Capital Management LP New York, NY3MShares$88.5 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$77.9 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$66.3 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$48.2 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.62MShares$47.7 Million0.08% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.01B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...